Heartseed (TSE:219A) Research & Development: 円0 Mil (TTM As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:219A Heartseed Inc TSE:219A
11 GF Score
Price 円1,495.00
View Full Analysis

What is Heartseed Research & Development?

Heartseed TSE:219A -4.41% 11 Research & Development is 円0 Mil as of Oct. 2025. GuruFocus rates TSE:219A with a GF Score™ of 11/100.

Research & Development is the aggregate amount of research and development expenses during the year. Heartseed's Research & Development for the three months ended in Oct. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 was 円0 Mil.

Heartseed  (TSE:219A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Heartseed Research & Development Related Terms

Heartseed Research & Development Historical Data

* Premium members only.

The historical data trend for Heartseed's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heartseed Research & Development Chart

Heartseed Annual Data
Trend Oct22 Oct23 Oct24 Oct25
Research & Development
0.00 0.00 0.00 0.00

Heartseed Quarterly Data
Oct22 Oct23 Apr24 Jul24 Oct24 Apr25 Jul25 Oct25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:219A
11GF Score
Heartseed Inc TSE:219A
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Heartseed Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Heartseed (TSE:219A) has a Research & Development of 円0 Mil as of Oct. 2025. Research and development expense is the total cost for research and development activities. View historical data on Heartseed and its competitors.
Is Heartseed's Research & Development too high?
Heartseed's current Research & Development is 円0 Mil. Overall, Heartseed has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Heartseed's Research & Development compare to VRTX and REGN?
Heartseed's Research & Development of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Heartseed and its competitors. Heartseed's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Heartseed stock overvalued right now?
Heartseed (TSE:219A) has a current Research & Development of 円0 Mil. The current Research & Development is 円0 Mil. Heartseed's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Heartseed (TSE:219A), the current Research & Development is 円0 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Heartseed Business Description

Address 1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is a Japanese biotechnology company focused on developing and commercializing regenerative medicine treatments for severe heart failure. The company's product candidate, HS-001, involves transplanting clusters of purified heart muscle cells derived from iPSCs to the patient's heart to treat heart failure, especially Heart Failure with reduced Left Ventricular Ejection Fraction (HFrEF), including conditions such as Dilated Cardiomyopathy, Old Myocardial Infarction, and Dilated phase of Hypertrophic Cardiomyopathy.
11GF Score

Get the complete analysis for TSE:219A

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,495.00
Price